QUT

Deformability Cytometry For Sepsis Risk Assessment

Product code
QUT
Device name
Deformability Cytometry For Sepsis Risk Assessment
Device class
Class 2
21 CFR
21 CFR 866.3215
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
2
Summaries archived here
2 (direct download)
510(k) clearances (all years, FDA)
3 (all years; only the last 3 years are listed here)

FDA classification definition

A semi-quantitative assay that measures cellular deformability and other physical properties of leukocytes in whole blood samples to aid the early detection of sepsis

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (2)

Last three years. Most recent: 2025-11-19.

NumberDecision dateApplicantDevice nameSummary
K2509122025-11-19Cytovale, Inc.IntelliSep TestPDF
K2505132025-03-21Cytovale, Inc.IntelliSep Test (CV-ICG-048)PDF

2 summaries are archived here for direct download.

Official FDA classification page: QUT
Classification and pathway per current FDA publications. Data from openFDA (CC0).